Business ❯ Market Analysis ❯ Investment Strategies

Analyst Ratings

Oracle Wedbush Securities Price Targets Loop Capital Nvidia Stock Valuation CrowdStrike Stock Apple Stock Risk Assessment Bank of America Securities HSBC AMD Stock Performance Citi Analyst Tyler Radke Wells Fargo Lululemon Athletica Inc. BWS Financial Stock Recommendations Seagate Stock Morgan Stanley Palantir Technologies Bullish Predictions Bank of America HPC/AI Opportunities Super Micro Stock Nvidia Stock JP Morgan

JPMorgan Upgrades Recursion, Raises Target to $11 as Shares Surge on AI Drug Signals

The call cites clinical readouts for REC‑4881 plus REC‑617 as evidence supporting the company's AI discovery platform.

Stories older than 24h

Tesla Confronts Sales Slump as Analysts Split on Autonomy and Valuation

CleanSpark Posts Strong FY25, Misses Q4, Repays Bitcoin-Backed Debt as It Pivots to AI Data Centers

Seagate Surges on AI-Driven Beat and Strong Outlook, Signaling a Storage Rebound

Wells Fargo Upgrades CoreWeave, Hikes Target to $170 on AI Compute Shortages

Oklo Extends Record Rally on Tennessee Fuel-Recycling Plan, DOE Picks and New Partnerships

Nebius Closes $4.16 Billion Financing After Microsoft AI Capacity Deal, Speeds Vineland Buildout

IREN Stock Hits New High on First Full-Year Profit and Nvidia Preferred-Partner Status

MongoDB Soars After Q2 Beat and Guidance Hike on Accelerating Atlas Growth

Wedbush Lifts Palantir Target to $160 as Shares Near Record High and Valuation Debate Deepens